23 53

Cited 2 times in

Palliative surgery as a bridge to systemic treatment for malignant bowel obstruction due to peritoneal metastases: A retrospective, case-control study

Authors
 Azharuddin Razak O  ;  Seung Yoon Yang  ;  Min Soo Cho  ;  Byung Soh Min  ;  Yoon Dae Han 
Citation
 ASIAN JOURNAL OF SURGERY, Vol.46(1) : 160-165, 2023-01 
Journal Title
ASIAN JOURNAL OF SURGERY
ISSN
 1015-9584 
Issue Date
2023-01
MeSH
Case-Control Studies ; Humans ; Intestinal Obstruction* / etiology ; Intestinal Obstruction* / surgery ; Palliative Care ; Peritoneal Neoplasms* / complications ; Peritoneal Neoplasms* / pathology ; Peritoneal Neoplasms* / surgery ; Retrospective Studies
Keywords
Carcinomatosis ; Malignant bowel obstruction ; Palliative chemotherapy ; Peritoneal metastasis
Abstract
Background: High-quality data on palliative surgery in patients with malignant bowel obstruction (MBO) caused by peritoneal metastases (PM) are lacking. We aimed to determine the utility of palliative surgery for such patients.Methods: We retrospectively analyzed patients considered for surgery for MBO, caused by PM, in our department from January 2019 to October 2020. None of them could tolerate a diet, despite conservative treatment. We investigated the clinical characteristics and perioperative outcomes and calculated overall survival (OS). Kaplan-Meier survival analysis was performed, with the log-rank test to evaluate differ-ences in OS rates. Multivariate Cox regression was performed to determine prognostic factors.Results: Sixty (67%) patients underwent surgery, whereas, 30 (33%) received the best supportive care (BSC) treatment. A better (p 1/4 0.002) median OS was observed in patients undergoing surgery (3.9 months) than in those receiving BSC (2.6 months). Severe complications were observed in 12 (20%) patients, including 30-day mortality (7 patients). Forty-eight (80%) patients in the surgery group could tolerate a diet and the hospital stay (mean +/- standard deviation) was 20.0 +/- 23.1 days. Re-obstruction was observed in five (8.3%) patients after 78.6 +/- 63.3 days. Patients in the postoperative chemo-therapy group exhibited a better (p < 0.001) median OS (12.3 months) than did those in the no -postoperative chemotherapy group (3.5 months). Only postoperative chemotherapy (hazard ratio 0.264, 95% confidence interval 0.143-0.487, p < 0.001) was identified as an independent prognostic factor.Conclusions: Compared with BSC, surgery is associated with a better OS in patients with MBO due to PM. Surgery should be considered as a bridge to systemic treatment for such patients.(c) 2022 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
Files in This Item:
T999202600.pdf Download
DOI
10.1016/j.asjsur.2022.02.028
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Min, Byung Soh(민병소) ORCID logo https://orcid.org/0000-0003-0180-8565
Han, Yoon Dae(한윤대) ORCID logo https://orcid.org/0000-0002-2136-3578
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/198400
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links